Jurgen Harting

Title: Jurgen Harting: Innovator in Cardiovascular Pharmaceutical Research

Introduction

Jurgen Harting is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that impact the cardiovascular system. With a total of 6 patents to his name, Harting's work is recognized for its potential therapeutic applications.

Latest Patents

Harting's latest patents include innovative compounds such as pyridaziny or oxodihydropyridazinyl chroman derivatives. These novel chroman derivatives are designed to show effects on the cardiovascular system, making them valuable for treating conditions like cardiac insufficiency, angina pectoris, high blood pressure, incontinence, and alopecia. Another significant patent involves pharmaceutical compositions containing 2-aryltetraazaindenes, which exhibit blood pressure regulation, myocardial contraction enhancement, and anti-ulcer activities.

Career Highlights

Throughout his career, Jurgen Harting has worked with prominent organizations, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent Gesellschaft. His experience in these companies has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Harting has collaborated with notable colleagues such as Manfred Baumgarth and Dieter Orth. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Jurgen Harting's contributions to pharmaceutical innovation, particularly in cardiovascular treatments, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving health outcomes through scientific research and innovation.